52,551 Shares in Ventas, Inc. $VTR Purchased by L & S Advisors Inc

L & S Advisors Inc purchased a new position in Ventas, Inc. (NYSE:VTRFree Report) in the 4th quarter, Holdings Channel.com reports. The firm purchased 52,551 shares of the real estate investment trust’s stock, valued at approximately $4,066,000.

Several other hedge funds have also recently added to or reduced their stakes in VTR. NewEdge Advisors LLC raised its position in Ventas by 856.1% in the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after purchasing an additional 7,097 shares in the last quarter. Empowered Funds LLC grew its stake in Ventas by 6.8% during the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after buying an additional 536 shares during the last quarter. Woodline Partners LP grew its stake in Ventas by 46.8% during the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after buying an additional 11,739 shares during the last quarter. Focus Partners Wealth grew its stake in Ventas by 130.4% during the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after buying an additional 12,233 shares during the last quarter. Finally, Gamco Investors INC. ET AL bought a new stake in Ventas during the second quarter worth about $805,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Insider Activity at Ventas

In other news, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director directly owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by company insiders.

Ventas Price Performance

VTR opened at $87.47 on Friday. Ventas, Inc. has a one year low of $61.76 and a one year high of $91.06. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. The company’s 50 day simple moving average is $85.05 and its 200-day simple moving average is $81.25. The stock has a market capitalization of $42.53 billion, a P/E ratio of 159.04, a price-to-earnings-growth ratio of 2.15 and a beta of 0.74.

Ventas (NYSE:VTRGet Free Report) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the company earned $0.84 earnings per share. Ventas’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Sell-side analysts anticipate that Ventas, Inc. will post 3.86 earnings per share for the current fiscal year.

Ventas Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, June 30th. Ventas’s dividend payout ratio is 378.18%.

Analyst Ratings Changes

VTR has been the topic of several research analyst reports. Jefferies Financial Group upped their price objective on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday. UBS Group upped their price objective on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research note on Monday, May 4th. Citigroup upped their price objective on shares of Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Argus set a $88.00 price objective on shares of Ventas in a research note on Tuesday, February 10th. Finally, Mizuho upped their price objective on shares of Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 4th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Ventas has an average rating of “Moderate Buy” and a consensus target price of $94.00.

Read Our Latest Stock Analysis on VTR

Ventas Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Featured Articles

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRFree Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.